4//SEC Filing
K-V Pharmaceutical Co 4
Accession 0001123292-13-001613
CIK 0000057055operating
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:49 PM ET
Size
8.1 KB
Accession
0001123292-13-001613
Insider Transaction Report
Form 4
O'Shea Robert J
10% Owner
Transactions
- Purchase
Common Stock
2013-11-18$46.50/sh+25,000$1,162,500→ 2,023,883 total
Silver Point Capital L.P.
10% Owner
Transactions
- Purchase
Common Stock
2013-11-18$46.50/sh+25,000$1,162,500→ 2,023,883 total
MULE EDWARD A
10% Owner
Transactions
- Purchase
Common Stock
2013-11-18$46.50/sh+25,000$1,162,500→ 2,023,883 total
Footnotes (1)
- [F1]Silver Point Capital, L.P. ("Silver Point") is the investment manager of Silver Point Capital Fund, L.P. and Silver Point Capital Offshore Fund, Ltd. (the "Funds") and, by reason of such status, may be deemed to be the beneficial owner of all of the reported securities held by the Funds. Silver Point Capital Management, LLC ("Management") is the general partner of Silver Point and as a result may be deemed to be the beneficial owner of all securities held by the Funds. Messrs. Edward A. Mule and Robert J. O'Shea are each members of Management and as a result may be deemed to be the beneficial owner of all of the securities held by the Funds. Silver Point, Management and Messrs. Mule and O'Shea disclaim beneficial ownership of the reported securities held by the Funds except to the extent of their pecuniary interests.
Documents
Issuer
K-V Pharmaceutical Co
CIK 0000057055
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000057055
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 5:49 PM ET
- Size
- 8.1 KB